Anticoccidial Drugs Market

Market Size (2021 to 2030)

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.

Market Share Insights

Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022.

Impact of COVID-19

The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Coccidiosis is a viral disease caused by a single-cell parasite that can only be seen under a microscope. It affects the intestinal tracts of animals.

Market Drivers

YOY growth in the prevalence of coccidiosis and increasing focus on animal health primarily accelerates the global anticoccidial drugs market. Anticoccidial drugs are the agents used to treat, prevent, and control coccidial infections.

Market Restraints

The need for more skilled persons in manufacturing appropriate drugs with correct dosage forms slowly restricts the global anticoccidial drug market. In addition, the availability of other drugs at a lower cost and fluctuations in the prices of final products due to less availability of raw materials are expected to limit the growth of the global anticoccidial drugs market.

Segments

By Drug Type

The global anticoccidial drugs market has been segmented into Antibiotic Anticoccidials, Ionophore Anticoccidials, and Chemical Derivative Anticoccidials. The ionophore anticoccidials segment witnessed the highest market share in 2022.

By Animal Type

Segments include Poultry, Swine, Fish, Cattle, and Companion Animal. The poultry animal segment led the market in 2022, and the companion animal segment is anticipated to witness a promising CAGR during the forecast period.

By Region Analysis

Regionally, the North American anticoccidial drugs market was the most dominating region in the global market in 2021. The APAC market is forecasted to be growing at a CAGR of 4.3% from 2022 to 2027.

Key Market Players

Noteworthy companies in the global anticoccidial drugs market include Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.

Recent Developments

In April 2022, Amlan International announced natural alternatives to anticoccidial drugs. In May 2020, Zoetis showed significant weight gain in suckling calves from implants.